From Pulse 2.0 · Amit Chowdhry · · 40s
Encora Therapeutics' MIT-Born Tremor Device Gets FDA Approval
MIT student project becomes FDA-approved tremor treatment after nine years.
In brief
MIT student project becomes FDA-approved tremor treatment after nine years. Encora Therapeutics' tremor device, developed from a 2017 MIT class project, received FDA clearance for essential tremor treatment in February 2026. Originally reported by Pulse 2.0.
MIT Student Project
Encora Therapeutics developed an FDA-cleared wearable treatment for essential tremor from a prototype created by MIT students in 2017.
Patient Demonstration
A Parkinson's patient demonstrated the prototype and experienced a dramatic reduction in hand tremor during the team's final presentation.
FDA Clearance
In February 2026, the U.S. Food and Drug Administration cleared the device for adults with essential tremor, nine years after the original MIT demonstration.
The big picture
Encora Therapeutics' tremor device, developed from a 2017 MIT class project, received FDA clearance for essential tremor treatment in February 2026.
